[]

Tomotaka Suzuki1, Dai Maruyama2

  • 1Department of Hematology and Oncology, Nagoya City University Graduate School of Medical Sciences.

概括

临床试验对于开发多发性骨髓瘤治疗非常重要. 未来的试验将专注于个性化药物和现实世界的数据,以提高治疗的疗效和效率.